National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

live freeze-dried lactic acid bacteria probiotic
A probiotic containing live, cultivated, freeze-dried lactic acid bacteria with gastrointestinal (GI) protective, anti-inflammatory, immunomodulating and potential antitumor properties. Oral administration of probiotic bacteria help maintain adequate colonization of the GI tract and modulate the composition of the normal microflora. Upon colonization of the GI tract, the probiotic bacteria form a protective barrier, interfere with the attachment of pathogenic bacteria and other harmful substances and may bind to and degrade carcinogens. This may prevent inflammation and possibly cancer. In addition, these bacteria produce lactic acid, thereby creating an acidic environment that is unfavorable for pathogens. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:VSL#3



Previous:Lithane, lithium carbonate, Lithobid, Lithonate, Lithotabs
Next:live-attenuated Listeria encoding human mesothelin vaccine CRS-207, LMB-1 immunotoxin, LMB-2 immunotoxin, LMB-7 immunotoxin, LMB-9 immunotoxin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov